# GT Analytics - Capsid AAV8-ELISA

SOP-051200

## Objective

Capsid concentration is determined for unknown samples.  

## Method Status

For detailed method status see either SOP-236462 and/or method history file DMD-211877.  

## Results - Current Reference

### Plate 1

| Sample type   | Sample Name                |   Pre-dilution | Result [cp/ml]   | CV [%]   | Comment      |
|:--------------|:---------------------------|---------------:|:-----------------|:---------|:-------------|
| control 01    | Kontrolle01                |             10 | [ 1.765e+11 ]    | 8.0      | test invalid |
| sample 01     | ORES18018_MCSGP1 L         |           2000 | **2.587e+13**    | 10.6     |              |
| sample 02     | ORES18018_MCSGP1 L         |           5000 | **2.641e+13**    | 8.6      |              |
| sample 03     | ORES18018_MCSGP1 E4        |           2000 | **3.873e+13**    | 1.8      |              |
| sample 04     | ORES18018_MCSGP1 E4        |           5000 | **4.189e+13**    | 8.7      |              |
| sample 05     | ORES18018_MCSGP1 E9        |           2000 | **3.900e+13**    | 12.9     |              |
| sample 06     | ORES18018_MCSGP1 E9        |           5000 | **4.420e+13**    | 9.6      |              |
| sample 07     | ORES18018_MCSGP1 Frac line |            500 | **1.519e+13**    | 10.7     |              |
| sample 08     | ORES18018_MCSGP2 Frac line |           1000 | **1.101e+13**    | 12.3     |              |
| sample 09     | Platte 1, Probe 9          |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 10     | Platte 1, Probe 10         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 11     | Platte 1, Probe 11         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 12     | Platte 1, Probe 12         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 13     | Platte 1, Probe 13         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 14     | Platte 1, Probe 14         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 15     | Platte 1, Probe 15         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 16     | Platte 1, Probe 16         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 17     | Platte 1, Probe 17         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 18     | Platte 1, Probe 18         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 19     | Platte 1, Probe 19         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 20     | Platte 1, Probe 20         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |
| sample 21     | Platte 1, Probe 21         |             10 | **<3.307e+9**    | NA       | <3.307e+9    |

\* sample will be retested

## Evaluation criteria

Validity of the assay: Intermediary control sample limits (3s) are: 1.119e+11 - 1.648e+11 cp/ml  

